Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G/A for Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2025.
Ikarian Capital, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- TRAW
- Shares outstanding
- 8,133,373 shares
- Disclosed Ownership
- 812,524 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 17:11:54 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 10% ownership in Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 17 Feb 2026, 17:11.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 10% | 812,524 | 0 | 812,524 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 10% | 812,524 | 0 | 812,524 | /s/ Neil Shahrestani | Neil Shahrestani |